XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -9.18%7.16B | -66.86%1.56B | -23.91%2.52B | 280.11%2.73B | 139.63%342M | 9.97%7.88B | 1.79%4.71B | 326.22%3.32B | -44.09%719M | -281.30%-863M |
Net income from continuing operations | 48.31%5.01B | 5.91%1.56B | 264.52%1.54B | -87.12%175M | 17.69%1.74B | -36.55%3.38B | 0.34%1.47B | -166.88%-933M | 1.57%1.36B | 31.53%1.48B |
Operating gains losses | -11.96%-1.74B | 14.58%-334M | 15.54%-326M | 15.90%-328M | -94.07%-753M | -10.05%-1.56B | -11.40%-391M | -10.92%-386M | -10.17%-390M | -7.78%-388M |
Depreciation and amortization | 3.63%4.36B | 7.55%1.14B | 1.86%1.09B | 2.68%1.07B | 2.42%1.06B | 2.51%4.21B | 1.05%1.06B | 2.58%1.07B | 4.50%1.04B | 1.97%1.03B |
Deferred tax | 88.31%-47M | -77.91%72M | -985.71%-304M | 180.59%299M | 65.35%-114M | 75.83%-402M | 1,711.11%326M | 94.76%-28M | 32.05%-371M | 45.26%-329M |
Other non cash items | -29.45%218M | 76.67%159M | 186.11%103M | -111.55%-29M | 77.94%-15M | 332.33%309M | -35.25%90M | 133.64%36M | 198.05%251M | -174.73%-68M |
Change In working capital | -171.62%-1.09B | -155.86%-1.14B | -90.83%316M | 211.43%1.43B | 37.24%-1.69B | 190.23%1.52B | -7.08%2.05B | 541.23%3.45B | -32,050.00%-1.29B | -200.22%-2.69B |
-Change in receivables | -1.21%-2.59B | -122.41%-1.07B | -1,320.75%-647M | -1,141.94%-323M | 74.68%-547M | -1,360.10%-2.56B | -154.71%-482M | -91.68%53M | 101.88%31M | -740.95%-2.16B |
-Change in inventory | -33.51%-1.47B | -29.14%231M | -218.52%-344M | -18.77%-715M | 10.28%-646M | 29.90%-1.1B | 331.21%326M | 73.07%-108M | -34.98%-602M | -22.66%-720M |
-Change in payables and accrued expense | -62.45%1.51B | -237.88%-819M | -69.70%1.08B | 328.95%1.46B | -144.49%-218M | 93.54%4.02B | -23.55%594M | 540.32%3.57B | -126.35%-639M | 255.06%490M |
-Change in other current assets | 65.37%-402M | 43.46%-160M | -88.11%-459M | 509.26%442M | 57.22%-225M | -13.05%-1.16B | 36.12%-283M | -5.63%-244M | -50.00%-108M | -87.19%-526M |
-Change in other working capital | -19.38%1.87B | -64.29%676M | 293.10%684M | 1,668.75%566M | -124.22%-54M | 174.47%2.32B | 67.52%1.89B | 596.00%174M | 112.36%32M | 546.00%223M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -9.18%7.16B | -66.86%1.56B | -23.91%2.52B | 280.11%2.73B | 139.63%342M | 9.97%7.88B | 1.79%4.71B | 326.22%3.32B | -44.09%719M | -281.30%-863M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 49.52%-1.53B | 20.35%-779M | 16.76%-715M | -17.66%-733M | 219.69%693M | -7.42%-3.04B | -4.26%-978M | -13.77%-859M | -0.81%-623M | -11.78%-579M |
Capital expenditure reported | -8.70%-2.63B | -32.80%-1.07B | 2.13%-552M | -2.09%-537M | 10.19%-467M | -5.55%-2.42B | 5.85%-805M | -9.51%-564M | -9.81%-526M | -18.45%-520M |
Net intangibles purchase and sale | 18.64%-611M | 23.72%-164M | 41.89%-129M | 3.13%-155M | -5.84%-163M | -54.21%-751M | -27.22%-215M | -66.92%-222M | -55.34%-160M | -87.80%-154M |
Net business purchase and sale | 29,816.67%1.8B | --512M | --0 | --0 | --1.28B | -78.57%6M | --0 | 110.00%6M | --0 | --0 |
Net investment purchase and sale | -244.95%-158M | -226.77%-161M | 150.79%32M | -148.28%-28M | 92.31%-1M | 161.93%109M | 118.97%127M | 24.10%-63M | 149.15%58M | 60.61%-13M |
Net other investing changes | 441.67%65M | 221.18%103M | -312.50%-66M | -360.00%-13M | -62.04%41M | -87.23%12M | -403.57%-85M | -155.17%-16M | -86.11%5M | 10,700.00%108M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 49.52%-1.53B | 20.35%-779M | 16.76%-715M | -17.66%-733M | 219.69%693M | -7.42%-3.04B | -4.26%-978M | -13.77%-859M | -0.81%-623M | -11.78%-579M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -46.17%-6.62B | 28.65%-1.87B | 51.28%-1.16B | -152.23%-1.58B | -283.12%-2.01B | 22.73%-4.53B | 8.11%-2.62B | -485.25%-2.38B | 66.63%-628M | 162.81%1.1B |
Net issuance payments of debt | -121.04%-2.5B | -109.76%-835M | 84.42%-12M | -180.49%-685M | -137.88%-972M | 2,343.33%11.9B | 647.25%8.56B | -103.72%-77M | 3,504.00%851M | 42,666.67%2.57B |
Net common stock issuance | 96.55%-444M | 99.51%-50M | 79.43%-294M | 92.62%-44M | 90.04%-56M | -359.15%-12.87B | -2,420.34%-10.28B | -131.98%-1.43B | 42.47%-596M | 24.36%-562M |
Cash dividends paid | 0.68%-3.22B | -4.56%-802M | 1.79%-823M | 2.49%-823M | 2.66%-769M | -3.55%-3.24B | 3.03%-767M | -5.54%-838M | -5.76%-844M | -6.04%-790M |
Net other financing activities | -42.59%-452M | -42.52%-181M | 12.12%-29M | 17.95%-32M | -77.97%-210M | 23.61%-317M | -47.67%-127M | 23.26%-33M | -69.57%-39M | 55.13%-118M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -46.17%-6.62B | 28.65%-1.87B | 51.28%-1.16B | -152.23%-1.58B | -283.12%-2.01B | 22.73%-4.53B | 8.11%-2.62B | -485.25%-2.38B | 66.63%-628M | 162.81%1.1B |
Net cash flow | ||||||||||
Beginning cash position | 5.33%6.63B | 22.47%6.68B | 11.50%6.01B | -4.85%5.61B | 5.33%6.63B | -19.89%6.29B | 1.39%5.46B | 13.09%5.39B | -2.43%5.89B | -19.89%6.29B |
Current changes in cash | -412.93%-992M | -197.40%-1.09B | 712.50%650M | 178.20%416M | -180.92%-972M | 120.86%317M | 32.58%1.12B | -87.50%80M | 56.18%-532M | 80.64%-346M |
Effect of exchange rate changes | -255.56%-28M | -378.57%-39M | 253.33%23M | -122.22%-4M | -900.00%-8M | 142.86%18M | -6.67%14M | 59.46%-15M | 151.43%18M | -93.33%1M |
End cash Position | -15.32%5.58B | -15.32%5.58B | 22.47%6.68B | 11.50%6.01B | -4.85%5.61B | 5.90%6.59B | 5.90%6.59B | 1.39%5.46B | 13.09%5.39B | -2.43%5.89B |
Free cash flow | -16.83%3.92B | -91.11%328M | -27.19%1.84B | 6,084.85%2.04B | 81.26%-288M | 7.38%4.72B | 2.41%3.69B | 1,746.72%2.53B | -95.27%33M | -3,315.56%-1.54B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |